BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30362115)

  • 1. Combined use of arginase and dichloroacetate exhibits anti-proliferative effects in triple negative breast cancer cells.
    Verma A; Lam YM; Leung YC; Hu X; Chen X; Cheung E; Tam KY
    J Pharm Pharmacol; 2019 Mar; 71(3):306-315. PubMed ID: 30362115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior anti-tumor efficacy of diisopropylamine dichloroacetate compared with dichloroacetate in a subcutaneous transplantation breast tumor model.
    Su L; Zhang H; Yan C; Chen A; Meng G; Wei J; Yu D; Ding Y
    Oncotarget; 2016 Oct; 7(40):65721-65731. PubMed ID: 27582548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
    Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
    Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combination of NVP-BKM120 with trastuzumab or RAD001 synergistically inhibits the growth of breast cancer stem cells in vivo.
    Yu F; Zhao J; Hu Y; Zhou Y; Guo R; Bai J; Zhang S; Zhang H; Zhang J
    Oncol Rep; 2016 Jul; 36(1):356-64. PubMed ID: 27175939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines.
    Parczyk J; Ruhnau J; Pelz C; Schilling M; Wu H; Piaskowski NN; Eickholt B; Kühn H; Danker K; Klein A
    BMC Cancer; 2021 Apr; 21(1):481. PubMed ID: 33931028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
    Ding T; Yang LJ; Zhang WD; Shen YH
    J Pharm Pharmacol; 2020 Jul; 72(7):969-978. PubMed ID: 32246778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant
    Chung SF; Kim CF; Chow HY; Chong HC; Tam SY; Leung YC; Lo WH
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antrodia salmonea induces G
    Chang CT; Hseu YC; Thiyagarajan V; Huang HC; Hsu LS; Huang PJ; Liu JY; Liao JW; Yang HL
    J Ethnopharmacol; 2017 Jan; 196():9-19. PubMed ID: 27986611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2.
    Pandiella A; Morís F; Ocaña A; Núñez LE; Montero JC
    Oncotarget; 2015 Oct; 6(32):32856-67. PubMed ID: 26439989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cell cycle arrest and inflammatory genes by combined treatment with epigenetic, differentiating, and chemotherapeutic agents in triple-negative breast cancer.
    Merino VF; Cho S; Nguyen N; Sadik H; Narayan A; Talbot C; Cope L; Zhou XC; Zhang Z; Győrffy B; Sukumar S
    Breast Cancer Res; 2018 Nov; 20(1):145. PubMed ID: 30486871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells.
    Lin Z; Zhang Z; Jiang X; Kou X; Bao Y; Liu H; Sun F; Ling S; Qin N; Jiang L; Yang Y
    Oncotarget; 2017 Mar; 8(11):17833-17848. PubMed ID: 28147319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ¹H NMR metabolomics analysis of the effect of dichloroacetate and allopurinol on breast cancers.
    Lefort N; Brown A; Lloyd V; Ouellette R; Touaibia M; Culf AS; Cuperlovic-Culf M
    J Pharm Biomed Anal; 2014 May; 93():77-85. PubMed ID: 24074721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of theophylline reduces necrotic effect of berberine, induces cell cycle arrest and PARP, HMGB1, Bcl-2 family mediated apoptosis in MDA-MB-231 breast cancer cells.
    Hashemi-Niasari F; Rabbani-Chadegani A; Razmi M; Fallah S
    Biomed Pharmacother; 2018 Oct; 106():858-867. PubMed ID: 30119256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNK-Bcl-2-mediated signalling pathways.
    Stander XX; Stander BA; Joubert AM
    Cell Physiol Biochem; 2015; 35(4):1499-526. PubMed ID: 25791820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acidosis-induced metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate.
    Schoonjans CA; Joudiou N; Brusa D; Corbet C; Feron O; Gallez B
    Cancer Lett; 2020 Feb; 470():18-28. PubMed ID: 31812695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Methoxy-5((3,4,5-trimethosyphenyl)seleninyl) phenol (SQ0814061), a novel microtubule inhibitor, evokes G2/M cell cycle arrest and apoptosis in human breast cancer cells.
    Xu J; Zuo D; Qi H; Shen Q; Bai Z; Han M; Li Z; Zhang W; Wu Y
    Biomed Pharmacother; 2016 Mar; 78():308-321. PubMed ID: 26898456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 25-methoxyl-dammarane-3β, 12β, 20-triol and artemisinin synergistically inhibit MDA-MB-231 cell proliferation through downregulation of testes-specific protease 50 (TSP50) expression.
    Wang D; Zhao Y; Wang Y; Rong Y; Qin H; Bao Y; Song Z; Yu C; Sun L; Li Y
    Tumour Biol; 2016 Sep; 37(9):11805-11813. PubMed ID: 27039397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined niclosamide with cisplatin inhibits epithelial-mesenchymal transition and tumor growth in cisplatin-resistant triple-negative breast cancer.
    Liu J; Chen X; Ward T; Pegram M; Shen K
    Tumour Biol; 2016 Jul; 37(7):9825-35. PubMed ID: 26810188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the combination of RAD001 and docetaxel on breast cancer stem cells.
    Zhang X; Zhang S; Liu Y; Liu J; Ma Y; Zhu Y; Zhang J
    Eur J Cancer; 2012 Jul; 48(10):1581-92. PubMed ID: 22420943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.